InvestorsHub Logo
Followers 833
Posts 119844
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Monday, 09/11/2017 5:12:42 PM

Monday, September 11, 2017 5:12:42 PM

Post# of 345950
Good news and bad news…

The bad news is not really news: Bavituximab has a street value of exactly zero. No paying partner will emerge to continue clinical development.

The good news is that Avid can stop making Bavi and reassign that production capacity to something that brings in revenue.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News